Literature DB >> 15918005

Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome.

Shuichiro Fujinaga1, Kazunari Kaneko, Masaru Takada, Yoshiyuki Ohtomo, Shunji Akashi, Yuichiro Yamashiro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15918005     DOI： 10.1007/s00467-005-1932-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

1.  Cyclosporine absorption profiling and therapeutic drug monitoring using C(2) blood levels in stable renal allograft recipients.

Authors:  G Einecke; I Mai; F Diekmann; L Fritsche; H-H Neumayer; K Budde
Journal:  Transplant Proc       Date:  2002-08       Impact factor: 1.066

2.  More stable and reliable pharmacokinetics with preprandial administration of cyclosporine compared with postprandial administration in patients with refractory nephrotic syndrome.

Authors:  Tetsuro Kusaba; Yusuke Konno; Shigeo Hatta; Tomoya Fujino; Takashi Yasuda; Hiroshi Miura; Hiroyo Sasaki; Jun Okabayashi; Mei Murao; Tsutomu Sakurada; Goro Imai; Sayuri Shirai; Shingo Kuboshima; Yoshinori Shima; Goichi Ogimoto; Takeo Sato; Keisou Masuhara; Kenjiro Kimura
Journal:  Pharmacotherapy       Date:  2005-01       Impact factor: 4.705

3.  Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.

Authors:  Stefano Rinaldi; Antonella Sesto; Paola Barsotti; Tullio Faraggiana; Francesco Sera; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

4.  Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients.

Authors:  G C Yee; T P Lennon; D J Gmur; M S Kennedy; H J Deeg
Journal:  Clin Pharmacol Ther       Date:  1986-10       Impact factor: 6.875

5.  Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts.

Authors:  Mark D Pescovitz; Ralph Barbeito
Journal:  Clin Transplant       Date:  2002-10       Impact factor: 2.863

6.  Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period.

Authors:  Salih Kavukçu; Alper Soylu; Mehmet Türkmen; Belde Kasap; Mukaddes Gümüştekin; Hüseyin Gülay
Journal:  Pediatr Nephrol       Date:  2004-03-31       Impact factor: 3.714
  6 in total
  6 in total

1.  Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy.

Authors:  Yoshiyuki Kuroyanagi; Yoshimitsu Gotoh; Katsuaki Kasahara; China Nagano; Naoya Fujita; Satoshi Yamakawa; Masaki Yamamoto; Asami Takeda; Osamu Uemura
Journal:  Clin Exp Nephrol       Date:  2017-07-11       Impact factor: 2.801

2.  Age effect on whole blood cyclosporine concentrations following oral administration in children with nephrotic syndrome.

Authors:  Katsumi Ushijima; Osamu Uemura; Takuji Yamada
Journal:  Eur J Pediatr       Date:  2011-11-26       Impact factor: 3.183

3.  Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome.

Authors:  S Fujinaga; K Kaneko; T Muto; Y Ohtomo; H Murakami; Y Yamashiro
Journal:  Arch Dis Child       Date:  2006-05-02       Impact factor: 3.791

4.  Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis.

Authors:  Nicholas J A Webb; Malcolm G Coulthard; Richard S Trompeter; Margaret M Fitzpatrick; Suzanne Stephens; Jan Dudley; Heather Maxwell; Simon Waller; Graham C Smith; Alan R Watson; David A Hughes; Brian G Keevil; Janice S Ellis
Journal:  Pediatr Nephrol       Date:  2007-09-26       Impact factor: 3.714

5.  Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial.

Authors:  Kazumoto Iijima; Mayumi Sako; Mari Saito Oba; Shuichi Ito; Hiroshi Hataya; Ryojiro Tanaka; Yoko Ohwada; Koichi Kamei; Kenji Ishikura; Nahoko Yata; Kandai Nozu; Masataka Honda; Hidefumi Nakamura; Michio Nagata; Yasuo Ohashi; Koichi Nakanishi; Norishige Yoshikawa
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-21       Impact factor: 8.237

6.  Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine.

Authors:  Shuichiro Fujinaga; Daishi Hirano; Naoto Nishizaki; Koichi Kamei; Shuichi Ito; Yoshiyuki Ohtomo; Toshiaki Shimizu; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2010-01-05       Impact factor: 3.714
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.